In this episode of Walk the Valley, Kata talks with Zdravko Obradović, CEO and founder of Clinical Trial Bid and EBS Clinical Research, about how the Balkans are reshaping the landscape of clinical trials.Zdravko takes us from the fax-machine era to the rise of AI-driven trials, showing how automation and smart systems can cut timelines from years to months without compromising safety. He shares how Serbia offers a compelling edge (shorter approvals, stronger investigator networks, and 30–40% lower costs) backed by a story of boosting recruitment from 42 to 126 patients in just nine weeks.We also dive into his mission to make clinical research more accessible through Clinical Trial Bid, an AI-powered platform that helps startups plan, connect, and execute trials faster and smarter.The takeaway? The future of clinical research isn’t just faster, it’s fairer. When technology removes barriers, even small innovators can bring life-changing ideas to market.

Clinical Trials Bid https://ctb.health/

EBS Clinical Research https://ebscro.com/

Zdravko's LinkedIn: https://www.linkedin.com/in/zdravko-obradovic-md-813218a6/